simendan has been researched along with Cardiovascular Pregnancy Complications in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avram, R; Desplantie, O; Ducharme, A; Jolicoeur, EM; Marquis-Gravel, G; Tremblay-Gravel, M | 1 |
Akgün, T; Biteker, M; Duran, NE; Gökdeniz, T; Gündüz, S; Kahveci, G; Kaya, H; Õzkan, M; Tanboğa, HÎ; Yildiz, M | 1 |
Benlolo, S; Katchatouryan, V; Lefoll, C; Mebazaa, A; Payen, D | 1 |
1 review(s) available for simendan and Cardiovascular Pregnancy Complications
Article | Year |
---|---|
The Medical Treatment of New-Onset Peripartum Cardiomyopathy: A Systematic Review of Prospective Studies.
Topics: Bromocriptine; Cardiomyopathies; Echocardiography; Female; Humans; Hydrazones; Pentoxifylline; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Puerperal Disorders; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Survival Rate; Ventricular Dysfunction, Left | 2015 |
1 trial(s) available for simendan and Cardiovascular Pregnancy Complications
Article | Year |
---|---|
Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial.
Topics: Adult; Cardiomyopathies; Cardiovascular Agents; Drug Therapy, Combination; Echocardiography; Female; Heart Ventricles; Humans; Hydrazones; Peripartum Period; Predictive Value of Tests; Pregnancy; Pregnancy Complications, Cardiovascular; Pyridazines; Simendan; Treatment Outcome; Vasodilator Agents; Ventricular Function, Left; Young Adult | 2011 |
1 other study(ies) available for simendan and Cardiovascular Pregnancy Complications
Article | Year |
---|---|
Successful use of levosimendan in a patient with peripartum cardiomyopathy.
Topics: Adult; Anesthesia, Obstetrical; Apnea; Cardiomyopathies; Female; Hemodynamics; Humans; Hydrazones; Pregnancy; Pregnancy Complications, Cardiovascular; Pyridazines; Simendan; Vasodilator Agents | 2004 |